eWellness Create New Patient Advertising Campaign to Support Partnership and Direct to Consumer Services

Culver City, CA, April 05, 2018 -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the state of the art PHZIO platform for the physical therapy and telehealth markets, announced that it has created a new patient advertising campaign to support its partnerships with Endeavor Plus and Life Wallet and for direct to consumer services. A  sample of one of our new ads can be seen at:
https://www.youtube.com/watch?v=OPqdL1g6Fus&feature=youtu.be

Douglas MacLellan, Chairman of EWLL said, “These new video ads will be tailor for each of our partners to communicate to their patient/employee pools. Additionally, we are starting to drive the above noted ad to the direct to consumer markets on Facebook and YouTube. Our ad describes a program that is a very low cost and incudes a live video evaluation and treatment plan for back pain relief. If you are experiencing back pain, give PHZIO a try. The initial evaluation is free for the rest of April 2018”.

About eWellness

eWellness Healthcare Corporation (OTCQB: EWLL) is the first physical therapy telehealth company to offer insurance reimbursable real-time distance monitored treatments. Our business model is to license our PHZIO (“PHZIO”) platform to any physical therapy (“PT”) clinic in the U.S. and or have large-scale employers use our PHZIO platform as a fully PT monitored corporate wellness program. The Company’s PHZIO home physical therapy exercise platform has been designed to disrupt the $30 billion physical therapy and the $8 billion corporate wellness industries. PHZIO re-defines the way physical therapy can be delivered. PHZIO is the first real-time remote monitored 1-to-many physical therapy platform for home use. Due to the real-time patient monitoring feature, the PHZIO platform is insurance reimbursable.

For more information on eWellness go to:

http://www.ewellnesshealth.com/
http://phzio.com/

http://prehabpt.com/

Safe Harbor Statement
This news release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as “could,” “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “proposed,” “planned,” “potential” and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about eWellness’ beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although eWellness believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. eWellness cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.

For additional information on eWellness Healthcare Corporation and its PHZIO telemedicine products please contact Mr. Darwin Fogt, CEO: 1-855-470-1700